AquaBounty Technologies (AQB)
(Delayed Data from NSDQ)
$1.03 USD
+0.04 (3.54%)
Updated Aug 30, 2024 03:42 PM ET
After-Market: $1.05 +0.03 (2.44%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Brokerage Reports
0 items in cart
AquaBounty Technologies, Inc. [AQB]
Reports for Purchase
Showing records 1 - 20 ( 60 total )
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
An Apparent Hunkering Down; Reiterate Neutral Rating
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Downturn Leads to Announced, But Not Executed Sale of Indiana on Route to Major Corporate Transformation; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Higher-for-Longer Is Not Music to the Ears; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Pioneer Build Waits Through Seasonal Salmon Pricing Slump; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Inflation Induced Construction Pricing Surprise; Reducing Price Target on Expected Delays; Reiterating Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Salmon Swim Upstream in March; Price Target Reset Lower in Stock Market Sympathy; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Quarter?s Revenue Down and Ohio Timeline Extended, Yet Advantages Still Apparent; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Seasonality Impacts September Revenue While New Ohio Farm Evolves, Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Greater Production Capacity Nears as Demand Rises - We Went to See for Ourselves; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
I-Day Highlights Improvements for OH 10MT Facility
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 In-Line, Rating Under Review as the Company Assesses OH Facility Cost
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Proving Execution While Advancing Systematically; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 In-Line, Rating Under Review as the Company Assesses OH Facility Cost
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: AquaBounty Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Escalating Harvest of Fish, Fry, and Eggs-Demand Rising Across the Board; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEDE K